
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8571923
[patent_doc_number] => 08338571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Recombinant factor VIII having increased stability'
[patent_app_type] => utility
[patent_app_number] => 12/179801
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 20958
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12179801
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/179801 | Recombinant factor VIII having increased stability | Jul 24, 2008 | Issued |
Array
(
[id] => 8189591
[patent_doc_number] => 08183345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Recombinant factor VIII having reduced inactivation by activated protein C'
[patent_app_type] => utility
[patent_app_number] => 12/179951
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16001
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183345.pdf
[firstpage_image] =>[orig_patent_app_number] => 12179951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/179951 | Recombinant factor VIII having reduced inactivation by activated protein C | Jul 24, 2008 | Issued |
Array
(
[id] => 8713479
[patent_doc_number] => 08399620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Purification of factor VIII using a mixed-mode or multimodal resin'
[patent_app_type] => utility
[patent_app_number] => 12/668530
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6845
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668530 | Purification of factor VIII using a mixed-mode or multimodal resin | Jul 10, 2008 | Issued |
Array
(
[id] => 6231438
[patent_doc_number] => 20100184672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'PROTEIN C FOR USE IN MAINTAINING HEMOSTASIS'
[patent_app_type] => utility
[patent_app_number] => 12/665540
[patent_app_country] => US
[patent_app_date] => 2008-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16817
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665540 | PROTEIN C FOR USE IN MAINTAINING HEMOSTASIS | Jun 17, 2008 | Abandoned |
Array
(
[id] => 5285353
[patent_doc_number] => 20090099028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Protein binding miniature proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/154667
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12469
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099028.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154667 | Protein binding miniature proteins and uses thereof | May 22, 2008 | Abandoned |
Array
(
[id] => 4859063
[patent_doc_number] => 20080267913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'METHOD TO ENHANCE HEMATOPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 12/126763
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4181
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12126763
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/126763 | METHOD TO ENHANCE HEMATOPOIESIS | May 22, 2008 | Abandoned |
Array
(
[id] => 4740547
[patent_doc_number] => 20080234200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'METHOD OF TREATMENT OF A METABOLIC DISEASE USING INTRANASAL ADMINISTRATION OF EXENDIN PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/124050
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 37549
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12124050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/124050 | METHOD OF TREATMENT OF A METABOLIC DISEASE USING INTRANASAL ADMINISTRATION OF EXENDIN PEPTIDE | May 19, 2008 | Abandoned |
Array
(
[id] => 7540568
[patent_doc_number] => 08058411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Method for producing mature VWF from VWF pro-peptide'
[patent_app_type] => utility
[patent_app_number] => 12/152762
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5982
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058411.pdf
[firstpage_image] =>[orig_patent_app_number] => 12152762
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/152762 | Method for producing mature VWF from VWF pro-peptide | May 15, 2008 | Issued |
Array
(
[id] => 12448542
[patent_doc_number] => 09982033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Factor VIII polypeptide titers in cell cultures
[patent_app_type] => utility
[patent_app_number] => 12/597118
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 9412
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597118
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597118 | Factor VIII polypeptide titers in cell cultures | Apr 29, 2008 | Issued |
Array
(
[id] => 6374824
[patent_doc_number] => 20100081187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/597456
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6790
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081187.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597456
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597456 | RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME | Apr 27, 2008 | Abandoned |
Array
(
[id] => 5564146
[patent_doc_number] => 20090136999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY OF CANCER AND INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/102292
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 67536
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136999.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102292
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102292 | Compositions and methods for immunotherapy of cancer and infectious diseases | Apr 13, 2008 | Issued |
Array
(
[id] => 6248752
[patent_doc_number] => 20100137211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'METHODS AND COMPOSITIONS FOR INTRA-ARTICULAR COAGULATION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/595308
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16742
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137211.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595308
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595308 | METHODS AND COMPOSITIONS FOR INTRA-ARTICULAR COAGULATION PROTEINS | Apr 10, 2008 | Abandoned |
Array
(
[id] => 6589072
[patent_doc_number] => 20100291603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'ASSESSING BLOOD COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 12/532453
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7285
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291603.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532453
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532453 | ASSESSING BLOOD COMPONENTS | Mar 27, 2008 | Abandoned |
Array
(
[id] => 11907087
[patent_doc_number] => 09775884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Solid fibrinogen preparation'
[patent_app_type] => utility
[patent_app_number] => 12/532547
[patent_app_country] => US
[patent_app_date] => 2008-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5867
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12532547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532547 | Solid fibrinogen preparation | Mar 20, 2008 | Issued |
Array
(
[id] => 13942
[patent_doc_number] => 07807778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Cysteine-containing peptide tag for site-specific conjugation of proteins'
[patent_app_type] => utility
[patent_app_number] => 12/075811
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13080
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807778.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075811
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075811 | Cysteine-containing peptide tag for site-specific conjugation of proteins | Mar 13, 2008 | Issued |
Array
(
[id] => 5322914
[patent_doc_number] => 20090060904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Vegetarian Protein A Preparation and Methods Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/046582
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5914
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060904.pdf
[firstpage_image] =>[orig_patent_app_number] => 12046582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/046582 | Vegetarian Protein A Preparation and Methods Thereof | Mar 11, 2008 | Abandoned |
Array
(
[id] => 6266427
[patent_doc_number] => 20100298223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'FIBRINOGEN FOR TREATMENT OF BLEEDING IN TRAUMA AND PLATELET DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/598562
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11529
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298223.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598562 | FIBRINOGEN FOR TREATMENT OF BLEEDING IN TRAUMA AND PLATELET DISORDERS | Feb 27, 2008 | Abandoned |
Array
(
[id] => 8713493
[patent_doc_number] => 08399632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules'
[patent_app_type] => utility
[patent_app_number] => 12/037735
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13893
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12037735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037735 | Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules | Feb 25, 2008 | Issued |
Array
(
[id] => 4663121
[patent_doc_number] => 20080254028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'CASPASE-8 BINDING PROTEIN, ITS PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 12/037719
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 30253
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254028.pdf
[firstpage_image] =>[orig_patent_app_number] => 12037719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037719 | CASPASE-8 BINDING PROTEIN, ITS PREPARATION AND USE | Feb 25, 2008 | Abandoned |
Array
(
[id] => 4786125
[patent_doc_number] => 20080139454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Method for stabilizing polypeptides lacking methionine'
[patent_app_type] => utility
[patent_app_number] => 12/069745
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2262
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069745
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069745 | Method for stabilizing polypeptides lacking methionine | Feb 12, 2008 | Issued |